The most feared complication of myasthenia gravis is the development of a 'crisis'. This term is applied to a myasthenic patient whenever respiratory distress and ventilatory inadequacy occur. One problem of therapy is that the disease affects different muscles to different degrees. The dose of anticholinesterase which relieves ophthalmoplegia, for example, may paralyse the respiratory muscles. When this is seen, the most important endpoint, namely respiratory function, should be used to determine the optimum dosage of therapy.
Recently a new mode of therapy was introduced for patients with myasthenia gravis. It consisted of long-term, high-single-dosage (100 mg), alternateday oral prednisone (Warmolts and Engel, 1972) . Because there are significantly fewer side effects of alternate-day versus daily prednisone therapy (Harter, Reddy, and Thorn, 1963) , the former is preferable.
The object of the present study is to determine whether alternate-day prednisone therapy is associated with significant fluctuations of respiratory function in myasthenic patients.
MATERIAL AND METHODS
PATIENTS Eight patients being followed regularly by the Medical Neurology Service (Table I) (1956b). The FRC was also determined by helium dilution (Meneely and Kaltreider, 1949) . Spirometric tests-forced vital capacity (FVC), expiratory volume in the first second (FEVY), maximal mid-expiratory flow (MMF) and peak flow (PF), and the maximal voluntary ventilation (MVV)-were determined with a Stead-Wells spirometer (Warren E. Collins); the diffusing capacity (DLco) was determined by the single-breath technique (Gaensler and Smith, 1973 
RESULTS
Routine pulmonary function results in the eight patients were within predicted norms (Kory et al., 1961; Boren, Kory, and Syner, 1966) except those of subject 8, which showed airways obstruction. Tables II and III show the effects of alternate-day prednisone therapy on respiratory function in the eight patients. These data of two consecutive days -a 'day on' and a 'day off' prednisone-represent the average of the respective four determinations for the 'day off' versus the 'day on'. Several studies were obtained throughout the day because preliminary data on subject 8 showed large intra- day on' and 'day off' with the exception of subjects 1 and 8. Table IV shows that, except for a decreased Pco.. in patients 4 and 6 (indicating hyperventilation), and a decreased Po2 in patient 8 (probably secondary to obstructive lung disease), the arterial blood gases measured during the 'day off' prednisone (when one might expect to see abnormalities, if there were any) are within normal limits. Tables II and III show that even though there are large individual changes of respiratory function, for the patients as a group there were no significant differences between 'day off' and 'day on'. Our studies indicate that patients without underlying lung disease do not have large changes in pulmonary function from the 'day on' to the 'day off' prednisone. Even though the reported data are only from two consecutive days, repeated pulmonary function tests obtained over periods of months to over two years, during follow-up visits of the patients, show that with the exception of subject 8 (who shows progressive obstructive lung disease as a result of smoking two packs of cigarettes per day), there have been only minor variations in lung function from 'days on' to 'days off'.
DISCUSSION
In our experience, when patients start prednisone therapy they show obvious differences in respiratory strength from the 'day on' to the 'day off'. During these early stages of therapy patients can remain off the mechanical ventilator for longer periods of time and have greater vital capacities during the 'day on'. Electromyographic evaluation of neuromuscular synaptic efficiency g 8pm confirms that during the early stages of prednisone therapy muscle strength is greater during the 'day on' (Warmolts and Engel, 1972) . The mechanism intra-and inter-day by which prednisone increases muscle strength in these patients is not well understood (Engel and Warmolts, 1971) . Later on these differences of 'day on' versus 'day off' become smaller and may V disappear in some patients. PATIENTS WITH Subject 1 has consistently shown a minor im-LTERNATE-DAY provement in all pulmonary function parameters during his day on prednisone (Tables II and III) (Tables 11 and III ; Fig. 1 ).
We are indebted to Drs. Harold Menke, and Claude Lenfant for their suggestions.
2- (Table 1) , none of the patients has had a myasthenic crisis or any episodes of acute respiratory insufficiency, and respiratory function has in general remained stable during the day. This contrasts with patients on anticholinesterase therapy in whom the FVC may fall substantially several times a day just before the administration of anticholinesterase drugs (Osserman and Genkins, 1971) . Thus alternate-day prednisone therapy not only decreases the frequency of myasthenic crises but also provides a smoother course of therapy when compared to previous treatment with anticholinesterase drugs. 
